- Condition: End-stage Renal Disease
Interventions: Device: Heparin-bonded vascular access graft; Device: Conventional ePTFE hemodialysis graft
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston
Not yet recruiting - verified May 2012 - Conditions: Magnesium Deficiency; Calcium Metabolism Disorders
Intervention: Dietary Supplement: vitamin D3
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; National Institutes of Health (NIH); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Conditions: Atrial Fibrillation; Electrical Cardioversion
Interventions: Drug: Magnesium Sulfate; Other: Placebo
Sponsors: State University of New York at Buffalo; State University of New York at Buffalo
Recruiting - verified May 2012 - Condition: Depression
Intervention: Dietary Supplement: Magnesium sulfate
Sponsors: University of Miami; University of Miami; Life Extension Foundation
Recruiting - verified May 2012 - Conditions: Cardiopulmonary Bypass; Altered Heparin Response
Interventions: Drug: Heparin; Drug: ATryn
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; GTC Biotherapeutics
Not yet recruiting - verified May 2012 - Conditions: Fabry Disease; Neuropathic Pain
Interventions: Drug: Gabapentin; Drug: placebo
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; Genzyme
Recruiting - verified April 2012 - Condition: Levator Ani Syndrome
Interventions: Drug: Nifedipine; Drug: Placebo Ointment Base
Sponsors: Vanderbilt University; Vanderbilt University
Not yet recruiting - verified April 2012 - Conditions: Alopecia; Breast Cancer
Intervention: Drug: compound 31543 Calcitriol
Sponsors: Berg Pharma,LLC; Berg Pharma,LLC
Not yet recruiting - verified April 2012 - Condition: Cancer
Intervention: Drug: SOR-C13
Sponsors: Soricimed Biopharma Inc; Soricimed Biopharma Inc
Not yet recruiting - verified April 2012 - Condition: Diarrhoea, Clostridium Difficile
Intervention: Drug: Calcium Aluminosilicate Anti-Diarrheal (CASAD)
Sponsors: Salient Pharmaceuticals Incorporated; Salient Pharmaceuticals Incorporated; Scott and White Hospital & Clinic; Texas A&M University
Recruiting - verified April 2012 - Condition: Steroid-induced Osteporosis, Glucocorticoid-induced Osteporosis
Interventions: Drug: Active denosumab with placebo for risedronate; Drug: Active risedronate with placebo for denosumab
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Conditions: Acromegaly; Nonfunctioning Pituitary Tumor
Intervention:
Sponsors: Emory University; Emory University
Recruiting - verified March 2012 - Condition: Essential Hypertension
Interventions: Drug: XOMA 985; Drug: Amlodipine Besylate; Drug: Perindopril Erbumine
Sponsors: XOMA (US) LLC; XOMA (US) LLC
Recruiting - verified March 2012 - Condition: Psoriasis
Intervention: Drug: calcipotriene
Sponsors: GlaxoSmithKline; Stiefel, a GSK Company; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Impaired Fasting Glucose
Interventions: Dietary Supplement: psyllium; Dietary Supplement: Microcrystalline Cellulose
Sponsors: Procter and Gamble; Procter and Gamble; Duke University
Recruiting - verified March 2012 - Condition: Degenerative Joint Disease of Hip and Knee.
Interventions: Drug: Placebo; Drug: Gapabentin
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey
Recruiting - verified March 2012 - Conditions: Bipolar I Disorder; Bipolar II Disorder
Interventions: Drug: Lithium/Lithium Carbonate; Drug: Divalproex; Drug: Lamotrigine; Drug: Quetiapine
Sponsors: The University of Texas Health Science Center at San Antonio; The University of Texas Health Science Center at San Antonio; National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: No Condition. Assessment of Healthy Volunteers.
Interventions: Drug: mibefradil; Other: Placebo
Sponsors: Tau Therapeutics LLC; Tau Therapeutics LLC; Celerion, Inc.; Dana-Farber/Partners CancerCare, Inc.; LifeWatch, Inc.
Recruiting - verified May 2012 - Conditions: Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer
Interventions: Drug: atorvastatin calcium; Drug: placebo
Sponsors: University of Nebraska; University of Nebraska; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Infection
Intervention: Other: Antimicrobial Solution
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Triax
Not yet recruiting - verified February 2012 - Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; Disseminated Neuroblastoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; High Risk Metastatic Gestational Trophoblastic Tumor; Juvenile Myelomonocytic Leukemia; Low Risk Metastatic Gestational Trophoblastic Tumor; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Plasma Cell Neoplasm; Previously Treated Childhood Rhabdomyosarcoma; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Rhabdomyosarcoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Gestational Trophoblastic Tumor; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Malignant Testicular Germ Cell Tumor; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Neuroblastoma; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Small Lymphocytic Lymphoma; Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage II Ovarian Epithelial Cancer; Stage II Ovarian Germ Cell Tumor; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Malignant Testicular Germ Cell Tumor; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Ovarian Epithelial Cancer; Stage III Ovarian Germ Cell Tumor; Stage III Small Lymphocytic Lymphoma; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Breast Cancer; Stage IV Childhood Hodgkin Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Stage IV Small Lymphocytic Lymphoma
Interventions: Drug: atorvastatin calcium; Procedure: peripheral blood stem cell transplantation; Procedure: allogeneic hematopoietic stem cell transplantation
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Not yet recruiting - verified February 2012 - Conditions: Acute Myeloid Leukemia/Transient Myeloproliferative Disorder; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Noncutaneous Extranodal Lymphoma; Previously Treated Myelodysplastic Syndromes; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia; Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; Waldenstrom Macroglobulinemia
Interventions: Drug: atorvastatin calcium; Drug: fludarabine phosphate; Radiation: total-body irradiation; Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation; Drug: cyclosporine; Drug: mycophenolate mofetil; Procedure: peripheral blood stem cell transplantation; Other: laboratory biomarker analysis
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Not yet recruiting - verified February 2012 - Condition: Hot Flashes in Men With Prostate Cancer Receiving Androgen Ablation Therapy
Interventions: Drug: Gabapentin; Drug: Venlafaxine
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified February 2012 - Condition: Angelman Syndrome
Intervention: Drug: minocycline
Sponsors: University of South Florida; University of South Florida
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: Magnesium Sulfate; Drug: Placebo
Sponsors: University of Louisville; University of Louisville
Recruiting - verified January 2012 - Condition: Calcium Deficiency
Interventions: Behavioral: Receive Kellogg's Nutri-Grain® cereal bars first; Behavioral: Receive Kellogg's Nutri-Grain® cereal bars second
Sponsors: Texas Woman's University; Texas Woman's University
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Drug: Nebulized magnesium sulfate
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified September 2011 - Condition: Cardiac Arrest
Interventions: Other: Standard Care; Other: Low Volume Hemofiltration; Other: High Volume Hemofiltration
Sponsors: University of Washington; University of Washington
Recruiting - verified January 2012 - Conditions: Obesity; Leptin Resistance
Interventions: Drug: Saline; Drug: Intralipid; Dietary Supplement: Water; Dietary Supplement: Soybean oil; Drug: Heparin
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center
Recruiting - verified January 2012 - Conditions: Acute Lymphoblastic Leukemia; Neuropathy; Neuropathic Pain
Interventions: Drug: gabapentin; Drug: placebo
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified January 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer; Gastric Cancer
Interventions: Drug: FOLFOX regimen; Drug: docetaxel; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Diabetic Nephropathy
Interventions: Drug: Sevelamer Carbonate; Drug: calcium carbonate
Sponsors: Mount Sinai School of Medicine; Gary Striker
Not yet recruiting - verified December 2011 - Condition: Acute Stroke
Intervention: Drug: Magnesium Sulfate
Sponsors: University of Southern California; University of Southern California; University of California, Los Angeles
Not yet recruiting - verified December 2011 - Conditions: Sciatica; Radiculopathy
Interventions: Procedure: epidural steroid injection; Procedure: Sham epidural steroid injection; Drug: Gabapentin; Drug: Placebo gabapentin
Sponsors: Johns Hopkins University; Johns Hopkins University; Walter Reed National Military Medical Center; Brooke Army Medical Center; Landstuhl Regional Medical Center; DC VA Hospital; San Diego Naval Hospital; Case Western Reserve University; Penn State-Hershey
Recruiting - verified March 2012 - Conditions: Osteoporosis; Bone Diseases, Metabolic
Intervention: Behavioral: Bone Mineral Density Result Letter and Bone Health Brochure
Sponsors: University of Iowa; University of Iowa; University of Alabama at Birmingham; Kaiser Permanente; University of Pittsburgh
Recruiting - verified March 2012 - Condition: Infection; Dialysis Catheter
Interventions: Drug: NAC/Tigecycline/Heparin combination lock solution; Drug: Standard anticoagulant (Heparin or Citrate)
Sponsors: University of California, San Diego; University of California, San Diego
Not yet recruiting - verified November 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: mibefradil dihydrochloride; Drug: temozolomide; Other: 3'-deoxy-3'-[18F]fluorothymidine; Other: pharmacological study
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center; National Cancer Institute (NCI); Tau Therapeutics LLC
Recruiting - verified April 2012 - Condition: Colorectal Cancer
Interventions: Drug: Tivozanib; Drug: Bevacizumab; Drug: mFOLFOX6
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc; AVEO Pharmaceuticals, Inc.
Recruiting - verified March 2012 - Condition: Bariatric Surgery Candidate
Interventions: Dietary Supplement: AquaVanta Chewable Tablet; Dietary Supplement: Flinstones Complete; Dietary Supplement: Nature Made Calcium Softgels; Dietary Supplement: Nature Made Calcium Softgels; Dietary Supplement: Twin Labs Iron Caps; Dietary Supplement: Rexall Vitamin B12 Tablet
Sponsors: Yasoo Health; Yasoo Health
Recruiting - verified November 2011 - Condition: Central Line-Associated Bloodstream Infection
Interventions: Drug: ethanol; Drug: heparin-saline placebo
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Bivalirudin; Drug: Heparin
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified October 2011 - Conditions: Arrhythmias, Cardiac; Heart Diseases; Cardiovascular Diseases; Implantable Cardioverter Defibrillator
Interventions: Drug: Azimilide Dihydrochloride; Drug: Placebo
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified May 2012 - Condition: Bone Marrow Transplantation
Interventions: Drug: Ronacaleret (100mg tablet); Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified November 2011 - Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Abraxane ( Nab-paclitaxel); Drug: Abraxane ( Nab-paclitaxel); Drug: Gemcitabine; Drug: Gemcitabine; Drug: ODSH ( 2-O, 3-O Desulfated Heparin); Drug: ODSH ( 2-O, 3-O Desulfated Heparin); Drug: Abraxane ( nab-paclitaxel); Drug: Gemcitabine
Sponsors: ParinGenix; ParinGenix; TGen Drug Development Services
Recruiting - verified April 2012 - Conditions: Tourniquet-induced Pain; Tourniquet-induced Hypertension
Interventions: Drug: gabapentin 600 mg po; Drug: Placebo pill given one hour before surgery
Sponsors: Baylor College of Medicine; Baylor College of Medicine
Not yet recruiting - verified September 2011 - Condition: Neoplasms
Interventions: Drug: Gemcitabine; Drug: BAY80-6946; Drug: Cisplatin; Drug: NaCl; Drug: BAY80-6964 fixed dose
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Condition: Chronic Kidney Disease
Interventions: Drug: Phoslyra; Drug: Sevelamer Carbonate
Sponsors: Fresenius Medical Care North America; Fresenius Medical Care North America
Recruiting - verified March 2012 - Conditions: Pain; Opioid Use, Unspecified, Uncomplicated
Interventions: Drug: Placebo infusion of .9 normal saline; Drug: administration of magnesium sulfate
Sponsors: Northwestern University; Northwestern University
Recruiting - verified February 2012 - Conditions: Degenerative Disc Disease; Spinal Stenosis; Spondylolisthesis
Intervention: Procedure: NanOss Bioactive bone void filler used in posterolateral gutter fusions
Sponsors: Pioneer Surgical Technology, Inc.; Pioneer Surgical Technology, Inc.
Recruiting - verified October 2011 - Condition: Primary Hypomagnesemia (Disorder)
Intervention: Drug: Magnesium Sulfate
Sponsors: CAMC Health System; CAMC Health System; Sara and Pauline Maier Foundation, Inc.
Recruiting - verified December 2011 - Condition: Insomnia
Intervention: Drug: Gabapentin
Sponsors: University at Buffalo; University at Buffalo
Recruiting - verified August 2011 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: bendamustine hydrochloride; Drug: cyclophosphamide; Drug: cytarabine; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: leucovorin calcium; Drug: methotrexate; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Hypertension; Renal Failure Chronic Requiring Hemodialysis; Fluid Overload
Interventions: Drug: Antihypertensive Agents; Other: Dry weight Challenge; Dietary Supplement: Extend dialysis treatment time and re-challenge estimated dry weight
Sponsors: University of New Mexico; University of New Mexico; Tufts Medical Center; Medical University of South Carolina; University of Pittsburgh
Recruiting - verified June 2011 - Conditions: Cognitive/Functional Effects; Leukemia; Neurotoxicity; Pain; Therapy-related Toxicity
Interventions: Drug: clofarabine; Drug: cyclophosphamide; Drug: cytarabine; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: hydrocortisone sodium succinate; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: prednisone; Drug: thioguanine; Drug: vincristine sulfate; Radiation: selective external radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Pancreatic Neoplasms
Interventions: Drug: oxaliplatin; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: fluorouracil; Other: laboratory biomarker analysis; Other: flow cytometry; Other: immunohistochemistry staining method; Other: pharmacological study; Drug: PF-04136309
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: HIV-1 Infection
Interventions: Drug: Atripla; Drug: Calcium Carbonate; Drug: Vitamin D3; Drug: Placebo for calcium carbonate; Drug: Placebo for vitamin D3
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: PKU
Interventions: Dietary Supplement: diet; Drug: sapropterin dihydrochloride
Sponsors: Children's Research Institute; Children's Research Institute; Georgetown University
Recruiting - verified March 2012 - Conditions: Anorexia Nervosa; Osteopenia; Osteoporosis
Interventions: Drug: rhIGF-1; Drug: Risedronate; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Conditions: Venous Ulcer; Infection
Interventions: Device: Restore Calcium Alginate Dressing; Device: AquaCel Ag Wound Dressing
Sponsors: Hollister Wound Care LLC; Hollister Wound Care LLC
Recruiting - verified November 2011 - Conditions: Obesity; Vitamin D Deficiency
Intervention: Dietary Supplement: Vitamin D3 and Calcium
Sponsors: The Methodist Hospital System; The Methodist Hospital System; Texas Woman's University
Not yet recruiting - verified July 2011 - Condition: Colorectal Cancer
Interventions: Biological: bevacizumab; Drug: FOLFIRI-bevacizumab regimen; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: sorafenib tosylate
Sponsors: National Cancer Institute (NCI); Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified October 2011 - Conditions: Arterial Dysfunction; Chronic Kidney Disease
Interventions: Drug: Cholecalciferol; Drug: Calcitriol
Sponsors: University of Colorado, Denver; University of Colorado, Denver; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Condition: HIV
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: Columbia University; Columbia University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Hypertension; Stage 2 Hypertension; Diabetes
Interventions: Drug: Valturna + amlodipine; Drug: valturna + placebo; Drug: Valturna + chlorthalidone
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Condition: Bipolar Disorder
Intervention: Drug: Lithium, valproate, lamotrigine
Sponsors: Emory University; Emory University
Recruiting - verified October 2011 - Conditions: Colon Cancer; Rectal Cancer
Intervention: Drug: Study Arm only (modified FOLFOX6)
Sponsors: Brown University; Debora G. Isdale; Memorial Hospital of Rhode Island; Rhode Island Hospital; The Miriam Hospital
Recruiting - verified May 2012 - Condition: Polycystic Ovary Syndrome
Intervention: Drug: folate-boosted 3 mg DRSP/20 μg EE-24/4 oral contraceptive
Sponsors: BC Women's Hospital & Health Centre; BC Women's Hospital & Health Centre; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Recruiting - verified March 2012 - Condition: Pain
Interventions: Drug: Ketorolac; Drug: Ibuprofen
Sponsors: Planned Parenthood League of Massachusetts; Planned Parenthood League of Massachusetts; Society of Family Planning
Recruiting - verified May 2012 - Conditions: Obesity; Morbid Obesity; Venous Thromboembolism; Atrial Fibrillation; Angina; Chest Pain
Intervention: Drug: Lean Body Weight-based heparin dose
Sponsors: Nazareth Hospital; Nazareth Hospital
Recruiting - verified August 2011 - Conditions: Infant, Very Low Birth Weight; Calcium Deficiency; Vitamin D Deficiency
Intervention: Dietary Supplement: 400 IU Cholecalciferol- Vitamin D Daily
Sponsors: Medical University of South Carolina; Medical University of South Carolina; National Center for Research Resources (NCRR)
Recruiting - verified November 2011 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
Interventions: Drug: FOLFOX regimen; Drug: carboplatin; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: paclitaxel
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Obesity, Morbid; Gastric Bypass
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Condition: Traumatic Brain Injury
Interventions: Device: Arctic Sun; Drug: Magnesium Sulfate
Sponsors: Department of Defense; Department of Defense
Recruiting - verified December 2011 - Conditions: Osteoporosis; Hypercalcemia of Malignancy; Hyperparathyroidism; Bone Diseases, Endocrine
Interventions: Drug: Parathyroid Hormone-related Protein (1-36); Drug: parathyroid hormone (1-34); Drug: PTH (1-34) and PTHrP (1-36)
Sponsors: University of Pittsburgh; University of Pittsburgh
Not yet recruiting - verified January 2012 - Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D and Calcium Citrate; Dietary Supplement: Placebo
Sponsors: Children's Hospital Los Angeles; Children's Hospital Los Angeles; The Leukemia and Lymphoma Society
Recruiting - verified September 2011 - Conditions: Liver Metastases; Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer
Interventions: Drug: oxaliplatin; Drug: leucovorin calcium; Drug: fluorouracil; Biological: bevacizumab; Procedure: therapeutic conventional surgery; Radiation: yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A; Other: laboratory biomarker analysis; Other: pharmacological study; Drug: irinotecan hydrochloride
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Negative Middle Ear Pressure
Interventions: Drug: Simethicone; Drug: Placebo
Sponsors: Children's Hospital of Pittsburgh; Children's Hospital of Pittsburgh; University of Pittsburgh
Recruiting - verified November 2011 - Conditions: Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Stage II Esophageal Cancer
Interventions: Biological: panitumumab; Drug: oxaliplatin; Drug: leucovorin calcium; Drug: fluorouracil; Radiation: radiation therapy; Procedure: therapeutic conventional surgery; Other: laboratory biomarker analysis; Other: high performance liquid chromatography; Genetic: DNA analysis; Genetic: polymorphism analysis; Other: pharmacological study; Other: pharmacogenomic studies
Sponsors: University of Nebraska; University of Nebraska; National Cancer Institute (NCI)
Recruiting - verified July 2011 - Conditions: Bacterial Infection; Mucositis; Neutropenia
Interventions: Drug: supersaturated calcium phosphate rinse; Other: placebo
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Anorexia Nervosa
Interventions: Drug: RhIGF-1 with transdermal 17-beta estradiol; Drug: Placebo and transdermal 17-beta estradiol
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; The Hospital for Sick Children
Recruiting - verified February 2012 - Condition: Breast Cancer
Intervention: Drug: Calcitriol
Sponsors: University of Rochester; University of Rochester
Recruiting - verified August 2011 - Condition: Metastatic Colorectal Cancer
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: irinotecan hydrochloride; Biological: bevacizumab; Biological: cetuximab; Drug: capecitabine; Genetic: mutation analysis; Genetic: gene expression analysis; Other: laboratory biomarker analysis; Other: immunohistochemistry staining method; Genetic: nucleic acid sequencing; Genetic: protein expression analysis; Genetic: polymerase chain reaction; Genetic: DNA analysis
Sponsors: Fox Chase Cancer Center; Fox Chase Cancer Center; National Cancer Institute (NCI)
Recruiting - verified October 2011 - Conditions: Cognitive/Functional Effects; Colorectal Cancer; Neurotoxicity
Interventions: Biological: bevacizumab; Drug: capecitabine; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI); Cancer and Leukemia Group B
Recruiting - verified February 2012 - Condition: Chronic Kidney Disease
Interventions: Drug: Sevelamer carbonate; Drug: Calcium acetate
Sponsors: Albany College of Pharmacy and Health Sciences; Albany College of Pharmacy and Health Sciences; Albany Medical College; Genzyme
Recruiting - verified December 2011 - Conditions: Chronic Kidney Disease; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Disease; Secondary Hyperparathyroidism
Interventions: Drug: cinacalcet capsule; Drug: placebo capsule; Drug: cinacalcet tablet; Drug: placebo tablet
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Condition: Rotavirus
Interventions: Biological: RotaTeq®; Biological: Rotarix®
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Condition: Leukemia
Interventions: Biological: alemtuzumab; Drug: cyclophosphamide; Drug: cytarabine; Drug: dasatinib; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide phosphate; Drug: fludarabine phosphate; Drug: leucovorin calcium; Drug: melphalan; Drug: mercaptopurine; Drug: methotrexate; Drug: vincristine sulfate; Genetic: polymerase chain reaction; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Cardiovascular Events
Interventions: Drug: Aliskiren and Amlodipine or HCTZ; Drug: Aliskiren; Drug: Amlodipine or HCTZ; Drug: Placebo
Sponsors: Novartis; Novartis; Population Health Research Institute
Recruiting - verified May 2012 - Conditions: Adenocarcinoma of the Esophagus; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Stage IV Esophageal Cancer; Stage IV Gastric Cancer
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: everolimus; Other: laboratory biomarker analysis; Other: immunohistochemistry staining method; Genetic: microarray analysis
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Dialysis; Cardiovascular Disease; Atherosclerosis; Inflammation; Hyperphosphatemia
Intervention: Drug: Sevelamer Carbonate (Renvela)
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified June 2011 - Condition: Diabetic Kidney Disease
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Recruiting - verified October 2010 - Condition: Leukemia
Interventions: Drug: cyclophosphamide; Drug: cytarabine; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: thioguanine; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Hyperparathyroidism; Chronic Kidney Disease
Interventions: Drug: sevelamer carbonate; Drug: placebo
Sponsors: Phelps, Kenneth R., M.D.; Phelps, Kenneth R., M.D.
Recruiting - verified June 2011 - Condition: Intracerebral Hemorrhage
Intervention: Drug: Nicardipine hydrochloride
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; Medical University of South Carolina; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2012 - Condition: Fractures
Interventions: Drug: Teriparatide; Drug: Placebo
Sponsors: Ohio Orthopedic Center of Excellence; Ohio Orthopedic Center of Excellence; Eli Lilly and Company
Recruiting - verified July 2011 - Conditions: Colorectal Cancer; Diarrhea; Neutropenia
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: UNC Lineberger Comprehensive Cancer Center; UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Colorectal Cancer
Interventions: Drug: celecoxib; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Other: placebo
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Cervical Radiculopathy
Interventions: Other: Gabapentin and/or Nortriptyline, Physical therapy; Procedure: Epidural Steroid Injections (ESI); Other: Combination treatment
Sponsors: Johns Hopkins University; Johns Hopkins University; Walter Reed Army Medical Center
Recruiting - verified September 2010 - Condition: Memory Impairment
Interventions: Drug: Lamotrigine; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Conditions: Secondary Hyperparathyroidism; End-Stage Renal Disease
Interventions: Drug: Paricalcitol; Drug: Calcitriol
Sponsors: Abbott; Abbott; North America Pediatric Renal Trials and Collaborative Studies (NAPRTCS)
Recruiting - verified January 2012 - Condition: Vulvodynia
Intervention: Drug: Gabapentin
Sponsors: University of Tennessee; University of Tennessee; University of Tennessee Health Science Center
Not yet recruiting - verified November 2011 - Conditions: Parkinson Disease; Accidental Falls
Interventions: Dietary Supplement: Vitamin D; Dietary Supplement: calcium; Other: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Oregon Health and Science University
Recruiting - verified January 2012 - Condition: Phenylketonuria
Interventions: Drug: Sapropterin dihydrochloride; Drug: Placebo
Sponsors: BioMarin Pharmaceutical; BioMarin Pharmaceutical
Recruiting - verified November 2011 - Conditions: Chemotherapeutic Agent Toxicity; Colorectal Cancer; Neuropathy; Neurotoxicity
Interventions: Drug: calcium gluconate; Drug: magnesium sulfate; Other: placebo
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Solid Tumors; Glioblastoma Multiforme; Recurrent Malignant Gliomas
Interventions: Drug: CTO; Drug: CTO and Temodar-R
Sponsors: Tactical Therapeutics, Inc.; Tactical Therapeutics, Inc.
Recruiting - verified October 2011 - Conditions: Hemophilia A; Hemophilia B; Vitamin D Deficiency
Intervention: Dietary Supplement: Vitamin D and calcium
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; CSL Behring
Recruiting - verified March 2010 - Condition: Advanced Solid Tumors
Interventions: Dietary Supplement: calcitriol; Drug: cisplatin; Drug: gemcitabine hydrochloride; Other: pharmacological study
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute
Recruiting - verified March 2012 - Condition: Scalp Psoriasis
Intervention: Drug: LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified March 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Otamixaban (XRP0673); Drug: Otamixaban matching placebo; Drug: Unfractionated Heparin; Drug: Unfractionated Heparin matching placebo; Drug: Eptifibatide; Drug: Eptifibatide matching placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Conditions: Mucositis; Multiple Myeloma
Interventions: Drug: 0.9% Sodium Chloride irrigation solution; Other: Cryotherapy (ice chips); Device: Calcium phosphate (Caphosol) Ca2+/PO43- mouth rinse
Sponsors: The University of Texas Health Science Center at San Antonio; The University of Texas Health Science Center at San Antonio; South Texas Veterans Health Care System
Recruiting - verified March 2012 - Condition: Drug Dependence
Intervention: Drug: 2-4 of the drugs listed below
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Breast Cancer
Interventions: Drug: Placebo; Drug: Denosumab
Sponsors: Amgen; Amgen; Daiichi Sankyo Inc.
Recruiting - verified May 2012 - Conditions: Pain; Breast Cancer; Lung Cancer
Interventions: Drug: Gabapentin; Drug: Placebo
Sponsors: Stanford University; Stanford University
Recruiting - verified September 2011 - Conditions: Adenocarcinoma of the Pancreas; Pancreatic Cancer; Stage III Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride; Drug: leucovorin calcium; Drug: fluorouracil; Drug: nelfinavir mesylate; Radiation: stereotactic body radiation therapy; Radiation: hypofractionated radiation therapy; Procedure: therapeutic conventional surgery; Other: pharmacological study; Genetic: polymorphism analysis; Other: pharmacogenomic studies; Genetic: protein expression analysis
Sponsors: University of Nebraska; University of Nebraska; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Condition: Rectal Neoplasms
Intervention: Other: 5 days of radiation followed by FOLFOX chemotherapy given every other week for 6 weeks
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified January 2012 - Condition: Obesity
Interventions: Behavioral: counseling on increasing calcium intake; Other: observation
Sponsors: Creighton University; Creighton University; National Institutes of Health (NIH)
Recruiting - verified November 2011 - Condition: Acute Myocardial Infarction
Interventions: Drug: Atorvastatin calcium; Drug: Inactive Placebo
Sponsors: The Western Pennsylvania Hospital; The Western Pennsylvania Hospital; West Penn Allegheny Health System
Recruiting - verified August 2011 - Condition: Bipolar Depression
Intervention: Drug: Lamotrigine 12 week open trial
Sponsors: Mayo Clinic; Mayo Clinic; National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Condition: Deep Venous Thrombosis
Intervention: Drug: Low-Molecular-Weight Heparin
Sponsors: University of Tennessee; University of Tennessee
Recruiting - verified June 2011 - Conditions: Chronic Kidney Disease; Vitamin D Deficiency
Interventions: Drug: Ergocalciferol; Drug: Calcitriol
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Kidney Foundation
Recruiting - verified July 2011 - Condition: Chronic Stable Plaque Psoriasis
Interventions: Drug: Clobex Spray; Drug: Vectical Ointment; Procedure: Excimer Laser
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified January 2012 - Condition: Hot Flashes
Intervention: Drug: Gabapentin
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified May 2012 - Condition: Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency
Intervention: Device: Coaptite®
Sponsors: Merz Aesthetics Inc.; Merz Aesthetics Inc.
Recruiting - verified May 2012 - Conditions: Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism; Thromboembolism; Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b); Drug: low molecular weight heparin/unfractionated heparin; Drug: warfarin
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified February 2012 - Conditions: Chronic Allograft Nephropathy; Chronic Kidney Disease; Chronic Renal Failure; Disordered Mineral Metabolism; End Stage Renal Disease; Hyperparathyroidism; Hypophosphatemia; Kidney Disease; Kidney Transplantation; Post Renal Transplantation
Interventions: Drug: Cinacalcet; Drug: Placebo
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: Sinusitis
Intervention:
Sponsors: University of Washington; Greg Davis
Recruiting - verified April 2012 - Conditions: Cannabis Dependence; Cannabis Withdrawal; Cognitive Deficits
Interventions: Drug: gabapentin 1200mg/day; Drug: Placebo
Sponsors: The Scripps Research Institute; The Scripps Research Institute
Recruiting - verified March 2012 - Condition: Atherosclerosis
Intervention:
Sponsors: Piedmont Healthcare; Piedmont Healthcare; Abbott
Recruiting - verified October 2011 - Condition: Postoperative Pain
Interventions: Drug: Gabapentin; Drug: pregabalin
Sponsors: Loma Linda University; Loma Linda University
Recruiting - verified March 2012 - Condition: Mouth Neoplasms
Interventions: Drug: 1,25-dihydroxyvitamin D3; Drug: celecoxib; Drug: 1,25-dihydroxyvitamin D3 + celecoxib
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Conditions: Bacterial Infections; Wounds
Interventions: Drug: Vancomycin 1.25-1.50% in a complex calcium alginate gel formulation; Drug: Vancomycin 1.25-1.5% compounded with a complex calcium alginate gel
Sponsors: Robert S Berman MD; Robert S Berman MD
Recruiting - verified November 2011 - Condition: Exercise-related Amenorrhea
Interventions: Drug: Transdermal 17Beta-estradiol, progesterone; Drug: Ethinyl Estradiol + Desogestrel; Dietary Supplement: Elemental Calcium and Vitamin D
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Conditions: Vitamin D Status; Secondary Hyperparathyroidism; Post-Menopause
Interventions: Drug: High Dose Vitamin D3; Drug: Low Dose Vitamin D3; Drug: Placebo; Drug: Placebo
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; National Institutes of Health (NIH)
Recruiting - verified November 2011 - Condition: HIV Infections
Interventions: Drug: Alendronate; Drug: Alendronate placebo; Dietary Supplement: Calcium carbonate/vitamin D
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Condition: Epilepsy
Interventions: Drug: levetiracetam; Drug: Lamotrigine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; UCB Young Investigator Research Program; National EpiFellows Foundation; UCB, Inc.; GlaxoSmithKline
Recruiting - verified December 2011 - Conditions: Breast Cancer; Hypercalcemia of Malignancy; Colon Cancer; Endocrine Cancer; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Lymphoma; Metastatic Cancer; Multiple Myeloma; Parathyroid Neoplasms; Renal Cancer; Thyroid Cancer; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma; Non-Small Cell Lung Cancer
Intervention: Drug: denosumab
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Condition: Osteoporosis
Interventions: Drug: Teriparatide; Drug: Risedronate; Drug: Placebo, weekly; Drug: Placebo, daily
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Spinal Cord Injuries
Intervention: Device: Mechanical Stimulation with the Vibration Plate
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Kessler Foundation
Recruiting - verified January 2012 - Condition: Colorectal Cancer
Interventions: Biological: bevacizumab; Drug: FOLFOX regimen; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: ursodiol; Genetic: RNA analysis; Genetic: gene expression analysis; Genetic: polymerase chain reaction; Genetic: western blotting; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: positron emission tomography (PET)
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Aggression
Interventions: Behavioral: CBI; Dietary Supplement: NUT
Sponsors: University of Pennsylvania; University of Pennsylvania; Pennsylvania Department of Health
Recruiting - verified March 2012 - Conditions: Obesity; Hypertension
Interventions: Drug: eplerenone, amlodipine; Drug: eplerenone; Drug: eplerenone; Drug: amlodipine
Sponsors: University of Mississippi Medical Center; University of Mississippi Medical Center
Recruiting - verified April 2012 - Conditions: Hypertension; Heart Failure
Interventions: Drug: Clevidipine butyrate injectable emulsion; Drug: standard of care IV antihypertensive treatment
Sponsors: The Medicines Company; The Medicines Company
Recruiting - verified January 2012 - Condition: Risperidone-induced Hyperprolactinemia
Intervention: Dietary Supplement: Calcium and Vitamin D
Sponsors: University of Iowa; University of Iowa; National Institutes of Health (NIH); Children's Miracle Network
Recruiting - verified August 2011 - Condition: Leukemia
Interventions: Biological: filgrastim; Biological: graft versus host disease prophylaxis/therapy; Drug: cyclophosphamide; Drug: cytarabine; Drug: dasatinib; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: leucovorin calcium; Drug: methotrexate; Drug: methylprednisolone; Drug: prednisone; Drug: vincristine sulfate; Genetic: cytogenetic analysis; Genetic: polymerase chain reaction; Other: flow cytometry; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation; Radiation: total-body irradiation
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Chronic Kidney Disease; Vitamin D Deficiency; Coronary Calcification; Disorders of Calcium and Bone Metabolism
Interventions: Drug: Calcitriol (Rocaltrol®); Drug: Paricalcitol
Sponsors: University of Pennsylvania; University of Pennsylvania; Abbott
Recruiting - verified November 2011 - Conditions: Vitamin D Deficiency; Insulin Resistance; Type 2 Diabetes Mellitus; Cardiovascular Disease; Hypertension
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Heart, Lung, and Blood Institute (NHLBI); American Diabetes Association
Recruiting - verified November 2011 - Condition: Healthy
Interventions: Drug: Imatinib mesylate; Dietary Supplement: calcium carbonate
Sponsors: University of Pittsburgh; University of Pittsburgh; Novartis Pharmaceuticals
Recruiting - verified November 2011 - Condition: Fecal Incontinence
Interventions: Drug: Psyllium powder; Drug: Loperamide
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified February 2012 - Condition: Bipolar Disorder
Intervention: Drug: lamictal
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Conditions: Intracerebral Hemorrhage; Stroke; Hypertension
Intervention: Other: Blood pressure management policies
Sponsors: The George Institute; The George Institute; National Health and Medical Research Council, Australia
Recruiting - verified February 2012 - Condition: Kidney Stones
Interventions: Drug: Alfuzosin; Drug: nifedipine; Drug: doxazosin; Drug: prazosin
Sponsors: United States Naval Medical Center, San Diego; United States Naval Medical Center, San Diego
Recruiting - verified April 2012 - Conditions: Lung Cancer; Precancerous Condition; Tobacco Use Disorder
Interventions: Dietary Supplement: calcitriol; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified December 2011 - Conditions: Paget's Disease of the Bone; Hypocalcemia
Intervention: Drug: Reclast®
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Breast Cancer; Depression; Hot Flashes; Psychosocial Effects of Cancer and Its Treatment
Interventions: Drug: citalopram hydrobromide; Drug: escitalopram oxalate; Drug: gabapentin; Drug: sertraline hydrochloride; Drug: tamoxifen citrate; Drug: venlafaxine; Genetic: molecular genetic technique; Other: high performance liquid chromatography; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: adjuvant therapy
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Chronic Hepatitis C; Atherosclerosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: panitumumab; Drug: everolimus; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: UNC Lineberger Comprehensive Cancer Center; UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Diabetic Neuropathic Pain; Chronic Low Back Pain
Interventions: Drug: donepezil; Drug: duloxetine; Drug: donepezil 2.5 mg and duloxetine 30mg; Drug: placebo; Drug: gabapentin
Sponsors: Wake Forest University; Wake Forest University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2012 - Condition: Osteopenia
Intervention: Other: exercise intervention
Sponsors: University of Missouri-Columbia; University of Missouri-Columbia; National Institutes of Health (NIH)
Recruiting - verified September 2011 - Condition: Autistic Disorder
Interventions: Dietary Supplement: B12; Dietary Supplement: Placebo; Dietary Supplement: folate; Dietary Supplement: B complex; Dietary Supplement: vitamin C; Dietary Supplement: cod liver oil; Dietary Supplement: Mineral complex; Dietary Supplement: carnitine
Sponsors: Arkansas Children's Hospital Research Institute; Arkansas Children's Hospital Research Institute
Recruiting - verified January 2012 - Conditions: Bipolar Disorder; Bipolar Depression
Interventions: Drug: citalopram + mood stabilizer; Procedure: FDG PET scans; Procedure: MRI structural scans; Procedure: Genotyping; Procedure: Blood Draw; Drug: placebo + mood stabilizer
Sponsors: Tufts Medical Center; Tufts Medical Center; National Institute of Mental Health (NIMH)
Recruiting - verified July 2011 - Condition: Leukemia
Interventions: Drug: asparaginase; Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide; Drug: lestaurtinib; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: methylprednisolone; Drug: pegaspargase; Drug: prednisone; Drug: therapeutic hydrocortisone; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Prostate Cancer
Interventions: Dietary Supplement: calcitriol; Drug: ketoconazole; Drug: therapeutic hydrocortisone
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; Department of Defense
Recruiting - verified January 2012 - Condition: Obstetric Labor, Premature
Intervention: Drug: Indomethacin and Nifedipine
Sponsors: Stanford University; Stanford University
Recruiting - verified June 2011 - Conditions: Leukemia; Lymphoma
Interventions: Drug: cyclophosphamide; Drug: cytarabine; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: nelarabine; Drug: pegaspargase; Drug: prednisone; Drug: thioguanine; Drug: vincristine sulfate; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Leukemia
Interventions: Biological: filgrastim; Drug: asparaginase; Drug: cyclophosphamide; Drug: cytarabine; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: etoposide phosphate; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: prednisone; Drug: therapeutic hydrocortisone; Drug: vincristine sulfate; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Colorectal Cancer
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Procedure: conventional surgery; Radiation: radiation therapy
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: leucovorin calcium; Drug: methotrexate; Drug: thiotepa; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Condition: Childhood Langerhans Cell Histiocytosis
Interventions: Drug: leucovorin calcium; Drug: methotrexate; Drug: prednisolone; Drug: vinblastine sulfate
Sponsors: National Cancer Institute (NCI); Histiocyte Society
Recruiting - verified May 2007 - Conditions: AIDS-Related Primary Central Nervous System Lymphoma; HIV
Interventions: Drug: Methotrexate; Biological: rituximab; Procedure: antiviral therapy; Drug: leucovorin calcium
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition
Interventions: Biological: therapeutic allogeneic lymphocytes; Drug: busulfan; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: mycophenolate mofetil; Procedure: peripheral blood stem cell transplantation; Radiation: Total Body Irradiation (TBI); Drug: Granulocyte colony-stimulating factor (G-CSF); Drug: Phenytoin; Drug: Methotrexate
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Hypertension
Interventions: Drug: Clonidine; Drug: Nitroglycerin transdermal; Drug: Dipyridamole/ Aspirin (Aggrenox); Drug: Desmopressin (DDAVP); Drug: Sildenafil; Drug: Nifedipine; Drug: Hydralazine; Drug: Hydrochlorothiazide; Drug: Placebo; Drug: Bosentan; Drug: Diltiazem; Drug: Eplerenone; Drug: guanfacine; Dietary Supplement: L-arginine; Drug: captopril; Drug: carbidopa; Drug: losartan; Drug: metoprolol tartrate; Drug: nebivolol hydrochloride; Drug: prazosin hydrochloride; Drug: tamsulosin hydrochloride; Other: Head-up tilt.
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Condition: Abruptio Placentae
Intervention: Drug: magnesium sulfate, Normal Saline
Sponsors: Stanford University; Stanford University
Recruiting - verified April 2012 - Condition: Cerebrovascular Accident
Interventions: Drug: Magnesium Sulfate; Drug: Normal Saline
Sponsors: University of California, Los Angeles; Jeffrey L. Saver; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified December 2011 - Conditions: Cutaneous T Cell Lymphoma; Hodgkin's Disease; Neoplasm; Non Hodgkin's Lymphoma; Peripheral T Cell Lymphoma
Interventions: Drug: Y-90 Humanized Anti-Tac; Drug: Calcium-DTPA
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified July 2011 - Conditions: Hyperparathyroidism; Hypocalcemia; Hypoparathyroidism; Parathyroid Neoplasm
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified June 2011 - Conditions: Hypocalcemia; Osteomalacia; Pseudohypoparathyroidism; Pseudo-Pseudohypoparathyroidism; Rickets
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2011 - Condition: Hypoparathyroidism
Intervention: Drug: PTH 1-34
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011
 |
Calcium Clinical Trials |
